Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Williams: Disorders of Carbohydrates and Fat Metabolism > I. Physiology of Insulin Secretion > Flashcards

I. Physiology of Insulin Secretion Flashcards

1
Q

Total weight of endocrine pancreas

A

1g (under 3% of the pancreas volume)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Most abundant cell type in the pancreas

A

Beta cells (60% of islet cells)
- Represent higher proportion of all endocrine cells in smaller islets, which are in closer contact with blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transporter of glucose into beta cells

A

Isoform 2 of the glucose transporter (GLUT2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First rate-limiting step in glucose metabolism

A

Phosphorylation of glucose to glucose-6-phosphate by glucokinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Enzyme responsible for first rate-limiting step in glucose metabolism

A

Glucokinase (functions as a glucose sensor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glucose metabolism raises ___ production

A

ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Elevated ATP production after glucose metabolism leads to ___

A

PRIMARILY: Closure of ATP-sensitive potassium channels and membrane depolarization

Other functions: Also serves as a major permissive factor for movement of insulin granules and for priming of exocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Closure of ATP-sensitive potassium channels and membrane depolarization leads to ___

A

Calcium entry through voltage-dependent calcium channels and elevation of calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Calcium entry through voltage-dependent calcium channels and elevation of calcium leads to ___

A

Exocytosis of insulin from readily releasable granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Effect of sympathetic stimulation on beta-cell function (through alpha2 receptor-mediated norepinephrine release)

A

Inhibits insulin secretion and potentiates glucagon secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effect of parasympathetic stimulation on beta-cell function (through M3 muscarinic-mediated acetylcholine release)

A

Enhances insulin AND glucagon release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When is the full complement of beta-cell mass established?

A

Within the first 5 years of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Average lifetime of beta cells

A

25 years (at islet periphery, a specialized microenvironment or neogenic niche harbors a population of transcriptionally immature (virgin) beta cells, which constitute a lifelong reservoir of new beta cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Estimated pancreatic insulin content

A

200 to 250 units (a 10-day supply for a healthy lean adult)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Physical description of an insulin secretory granule

A

300-350 nm in diameter, with electron-dense core composed of tightly packed crystals of insulin hexamers stabilized by one calcium and two zinc ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Functional description of an insulin secretory granule

A

1) only a small fraction (much less than 1%) is secreted in response to acute in vitro glucose stimulation
2) granule half-life is less than 5 days (with intracellular degradation starting already within about 3 days)
3) younger granules are fewer but more mobile than older granules even if they come from deep in the cytoplasm and thereform form a readily releasable pool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The estimated pancreatic insulin content is adequate for how many days supply in a health lean adult?

A

10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How much (in percentage) of the granules is secreted in response to acute in vitro glucose stimulation?

A

<1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Half life of beta cell secretory granule

A

5 days (with intracellular degradation starting already within about 3 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Method for assessing insulin secretion in vivo

A

Measurement of C-peptide

1) C-peptide is co-secreted with insulin in equimolar amounts as a consequence of proinsulin cleavage
2) C-peptide is NOT extracted by the liver
3) C-peptide clearance - half of which occurs through the kidney - is approximately constant in any given individual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

TRUE or FALSE: C-peptide is extracted by the liver

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Primary clearance of C-peptide

A

Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What do you call the mathematical procedure in which insulin secretion is calculated?

A

Deconvolution (reconstructs the pancreatic insulin secretion rate in pmol/min as it occurs before hepatic insulin degradation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How much of C-peptide is degraded by the kidneys?

A

~85% (15% of renal C-peptide uptake is excreted intact into the urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Measurements of the ratio of urinary ____ to creatinine have been shown to be reasonably well correlated with postprandial C-peptide levels (indicator of residual beta-cell function in patients with T1D)

A

C-peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Measurements of the ratio of urinary C-peptide to creatinine have been shown to be reasonably well correlated with ___

A

Postprandial C-peptide levels (indicator of residual beta-cell function in patients with T1D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Insulin clearance occurs through 2 principal routes depending on the site of entry of the hormone into circulation:

A

1) peripheral (or exogenous) pMCRI

2) prehepatic (or endogenous) eMCRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How is peripheral (or exogenous) insulin clearance determined?

A

Ratio of exogenous insulin infusion rate to arterial plasma insulin concentration at steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How is prehepatic (or endogenous) insulin clearance determined?

A

Ratio between endogenous insulin secretion - reconstructed from C-peptide deconvolution - and arterial plasma insulin concentration at steady state

30
Q

How to estimate fractional hepatic insulin extraction

A

Fractional difference of endogenous and exogenous insulin clearance

31
Q

What is the fraction of portal insulin that is removed by the liver in its first pass?

A

65% (ranging between 50% and 70%)

32
Q

What is the fraction of insulin that is removed by the liver overall (first pass plus recirculation)?

A

Approximately 80%

33
Q

How is insulin cleared once in the systemic circulation?

A

Recirculated and further cleared by liver (overall contribution 80%), and, to a lesser extent, by skeletal muscle and the kidneys

(In the fed state, contribution of skeletal muscle is decreased and that of the kidney is increased, but together still contribute no more than 20% to overall insulin clearance)

34
Q

During FASTING, what is the relationship of fasting prehepatic insulin concentrations to peripheral insulin levels?

A

Linear fashion, with an average ratio of 4:1

35
Q

In the FED state, what is the relationship of fasting prehepatic insulin concentrations to peripheral insulin levels?

A

Endogenous clearance is lower than in the fasting state as a consequence of saturation of liver extraction –> Ratio of prehepatic to peripheral insulin is progressively lower as pancreatic insulin release increases

36
Q

Antidiabetic agent that is known to reduce insulin clearance

A

Sulphonylureas

37
Q

Association of insulin clearance with insulin sensitivity - positive or negative?

A

Positive (regardless of the temporal sequence of changes in these two functions)

38
Q

What is responsible for the tightest physiologic feedback on insulin secretion?

A

Plasma glucose concentration

39
Q

TRUE or FALSE: Insulin action is functionally relatively stable within any given individual

A

TRUE (Insulin sensitivity vary by 30-80% during 24 hours of free living; can at best double with physiologic or pharmacologic intervention)

40
Q

TRUE or FALSE: Insulin secretion can vary manyfold in the same person in a matter of minutes

A

TRUE

41
Q

Direct technique of determining the insulin clearance, sensitivity, etc

A

Euglycemic hyperinsulinemic clamp

42
Q

3 main modes of beta-cell response

A

1) first-phase or acute insulin secretion

2) glucose sensitivity

3) potentiation of insulin secretion

43
Q

Describe first-phase insulin release

A

Sharp and short-lived peak of insulin secretion elicited by a brisk rise in glucose levels

Magnitude depends on the size of the glucose stimulus

Can also be represented as a function of the glucose rate of change (also called rate sensitivity, anticipation, or derivative component)

Contributes an estimated one-tenth (about 3 nmol/m2) of suprabasal secretion during a 2-hour OGTT

44
Q

What is “potentiation”?

A

It is when the dose-response relationship between glucose level and insulin secretion is enhanced, as when prior exposure to glucose leads to a greater insulin secretion on subsequent exposure. It may be generated by a glucose “memory”, incretins, or factors such as glucagon, cholinergic stimuli, other nutrients such as fructose, or drugs including sulfonylureas.

45
Q

TRUE or FALSE: Maintenance of glucose homeostasis depends not only on the absolute amount of insulin release but also on the time dynamics of the secretory response.

A

TRUE

46
Q

TRUE or FALSE: In hyperglycemic patients, fasting insulin secretion is generally lower than in normoglycemic subjects at each level of obesity.

A

FALSE. It is generally HIGHER.

47
Q

Frequency of detectable pulses of insulin concentration in the portal vein blood

A

5- to 14-minute intervals (Pulsatile secretion is disrupted in hyperglycemic states)

48
Q

Proposed marker of beta-cell function

A

Ratio of proinsulin to insulin concentrations (or absolute proinsulin concentration adjusted for insulin) in a fasting plasma sample

49
Q

Insulin secretory response to intravenous glucose - Hyperglycemic clamp (square wave of hyperglycemia)

A

Typically biphasic, with an initial sharp insulin secretory burst lasting about 5 to 8 minutes (first-phase secretion), followed by a transient decrease and then a progressive slow increase, which continues as long as hyperglycemia is maintained (second-phase secretion)

50
Q

TRUE or FALSE: The amount of insulin secreted during the first phase (also referred to as acute insulin response) is NOT dependent on the magnitude of the glucose rise.

A

FALSE. It IS dependent. In a typical +126 mg/dL hyperglycemic clamp, it is approximately 4 nmol per square meter of body surface area (~1 unit in a 70-kg adult).

51
Q

TRUE or FALSE: Attenuated first-phase insulin secretion is a very sensitive marker of early beta-cell dysfunction.

A

TRUE

52
Q

TRUE or FALSE: Higher glycemic plateaus elicit larger secretory responses (of insulin).

A

TRUE

53
Q

TRUE or FALSE: As multiple glucose steps are applied in sequence, the secretory response progressively increases.

A

FALSE

If multiple glucose steps are applied in sequence, the first-phase response is progressively attenuated while second-phase secretion increase in proportion to the height of the glycemic plateaus.

54
Q

Insulin secretory response to intravenous glucose - Intravenous glucose tolerance test

A

Also with biphasic insulin response. In contrast to the hyperglycemic state, glucose concentrations fall rapidly after the initial peak, and second-phase secretion is NOT sustained but TRANSIENT with a multiphasic pattern.

55
Q

TRUE or FALSE: Prolonged (2-4 days) exposure to mild hyperglycemia markedly decreases insulin secretion.

A

FALSE

Prolonged (2-4 days) exposure to mild hyperglycemia markedly enhances insulin secretion, with a steepening of the dose-response curve.

56
Q

When glucose is ingested, what is typical number of hours it takes for plasma glucose level to peak and return to baseline?

A

Plasma glucose levels typically peak at 0.5 to 1.0 hour and return to baseline by 2 hours post ingestion.

57
Q

What do you call the phenomenon wherein, with consecutive nutrient loads, the plasma glucose and insulin secretory responses are attenuated during the second, as compared with the first, meal

A

Staub-Traugott effect

58
Q

What causes the Staub-Traugott effect?

A

This is due to persistent suppression of endogenous glucose production by the hyperglycemia and hyperinsulinemia induced by the first load and to enhanced potentiation of insulin release.

59
Q

TRUE or FALSE: The beta cell protects against hypoglycemia during a prolonged fast but retains the potential to efficiently increase insulin production on refeeding.

A

TRUE

60
Q

TRUE or FALSE: If glucose is ingested rather than infused, insulin secretion is higher at the same glucose levels.

A

TRUE (due to incretins - GIP and GLP1)

61
Q

What are the 4 features of in vivo incretin effect that are reasonably well established?

A

1) GLP1 and GIP are released in phase with insulin and glucose concentrations

2) When gastric emptying is accelerated (e.g., following gastric bypass surgery), both the glucose and insulin peaks are anticipated and GLP1 levels are much higher if still synchronous with insulin

3) Glucose-induced and incretin-induced potentiation of insulin secretion - as resolved by modeling of isoglycemic experiments - have different time courses and relation to glucose tolerance

4) Strength of potentiation depends on the stimulus and the quality of beta-cell function

62
Q

TRUE or FALSE: Acute insulin response (AIR) is directly proportional to insulin sensitivity.

A

FALSE

AIR has a RECIPROCAL relationship with insulin sensitivity. This likely reflects adaptation of the beta cell to impaired insulin action, which sets in as a steep increment in secretion as insulin sensitivity declines.

63
Q

TRUE or FALSE: Insulin resistance raises the setpoint of beta-cell function.

A

TRUE

Insulin resistance raises the setpoint of beta-cell function, whereby absolute measures of insulin secretion (fasting, AIR, and postglucose) are chronically upregulated. (but postprandial glucose excursions are less influenced)

64
Q

TRUE or FALSE: The beta-cell mass in obese individuals is expanded.

A

TRUE (probably due to insulin resistance which raises the setpoint of beta cell function, and, hence, insulin secretion; but many of whom have normal beta-cell glucose sensitivity and glucose tolerance)

65
Q

Effect of mutation in one of at least six different genes of MODY (autosomal dominant mode)

A

Hyperglycemia of variable severity in young, nonobese subjects (typically younger than 25 years) with a multigenerational family history of diabetes

66
Q

Mutation in MODY2

A

Heterozygous private mutation of the gene (GCK) encoding glucokinase resulting in partial enzyme deficiency and a loss of beta-cell glucose sensitivity

67
Q

Mutations in MODY1, MODY 2, MODY3, MODY4, MODY5, and MODY 6

A

MODY 1 - HNF4 alpha
MODY 2 - glucokinase
MODY 3 - HNF1alpha
MODY4 - insulin promoter factor 1
MODY 5 - HNF1beta
MODY 6 (or BETA2) - neurogenic differentiation 1 transcription factor

Causes loss of beta-cell glucose sensitivity on a graded glucose infusion test and rapidly progressing hyperglycemia, as well as beta-cell dysfunction.

68
Q

TRUE or FALSE: Transcription factors responsible for beta cells are also expressed in other tissues.

A

TRUE

Because these transcription factors are also expressed in other tissues (liver and kidney), the mutations produce a clinical phenotype in which islet dysfunction is associated with other abnormalities, particularly microvascular complications.

69
Q

Insulin action

A

Plasma insulin lowers plasma glucose by promoting tissue glucose uptake (primary feedback), and restrains lipolysis and protein breakdown, thereby lowering circulating FFAs and amino acids (secondary feedback loop).

70
Q

How does insulin resistance affect insulin secretion.

A

It increases baseline secretory activity and increments the stimulatory signals (i.e., glucose, FFAs, and amino acids)

71
Q

TRUE or FALSE: Absolute insulin release is directly proportional to glucose sensitivity of the beta cell.

A

FALSE

There is an OPPOSITE behavior of absolute insulin release and glucose sensitivity of the beta cell across stages of glucose tolerance. In impaired fasting glycemia, for example, insulin output is increased by 15%, insulin sensitivity (on an insulin clamp) is only slightly impaired, but glucose sensitivity is 30% lower.

72
Q

TRUE or FALSE: Beta-cell glucose sensitivity is a powerful negative predictor of incident T2D in nondiabetic cohorts above and beyond the impact of conventional risk factors (sex, age, BMI, family history, etc).

A

TRUE

Williams: Disorders of Carbohydrates and Fat Metabolism (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions